A prerequisite for cutting-edge competitive research is presented by high-end technology. In this context, Laboratory of molecular therapy (IBT CAS/BIOCEV) have established a new instrument from Akoya Biosciences, Phenocycler, that allows to study spatial proteomics in biological samples.
International research team led by Libor Macurek (Institute of Molecular Genetics, Czech Academy of Sciences), Robert Grosse (Institute for Clinical and Experimental Pharmacology and Toxicology, University of Freiburg) and Zdenek Lansky (Institute of Biotechnology, Czech Academy of Sciences) identified a new mechanism of the crosstalk between microtubules and actin cytoskeleton during cell division. ...
In EMBO’s 60th anniversary year, 100 new Members and 20 Associate Members join the community. One of them is Zdeněk Lánský, head of the Laboratory of Structural Proteins.
Scientists from the Institute of Biotechnology have successfully developed novel small protein blockers of human interleukin-6 receptor alpha (IL-6Rα) and, in collaboration with researchers from other academic institutions, extensively functionally tested.
Research team of the Laboratory of Ligand Engineering with its collaborators from Palacky University Olomouc (UPOL) has recently reported on engineering of small PD-1 binding proteins named Myomedins MBA that benefit diagnosis of non-small cell lung carcinoma (NSCLC) patients in vitro and monitoring PD-1 positive cell populations in vivo using positron emission tomography (PET/CT).
Mitochondria harbour two important pathways: the Krebs cycle and oxidative phosphorylation (OXPHOS). While Krebs cycle is a hub of catabolic and anabolic pathways essential for proper physiology and function of a cells, OXPHOS is the major source of cellular energy in the for of ATP. Thus, the two pathways are under strict control. They are connected with each other by mitochondrial respiratory complex II (CII), also referred to as succinate de-hydrogenase (SDH). ...
The President of the Czech Science Foundation (GACR) together with the Minister for Science, Research and Innovation awarded the five best scientific projects at the 20th anniversary ceremony of the Czech Science Foundation President's Awards yesterday (12 October 2023) at the Martinský Palace. The award recipients from all areas of basic research have contributed to a significant expansion of knowledge in the field and will lead to further applications.
Scientists from the Institute of Biotechnology (BTU) of the CAS at the Biotechnology and Biomedicine Centre of the Czech Academy of Sciences and Charles University (BIOCEV) and the Institute of Clinical and Experimental Medicine (IKEM) have elucidated the crucial role of the NEUROD1 protein in the development of severe diabetes. MODY6 diabetes is a subtype of diabetes caused by a mutation in the neurogenic differentiation factor 1 (NEUROD1) gene. ...
For the excellent results of the project "The role of NEUROD1 and ISL1 in the development of inner ear neurons" Gabriela Pavlínková received an honorary recognition from the President of the Grant Agency of the Czech Republic (GAČR) last week.
Cancer cells need an immense amount of building material to proliferate. When they run out, they are able to persuade healthy nearby cells to supply them. How they do so is the subject of research done by Kateřina Rohlenová from the Institute of Biotechnology of the CAS: “We already know quite well what happens on the inside of cancer cells. We now want to map what happens in their surroundings. ...
